Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure

NCT05870709 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Terminated due to business decision

Conditions

Heart Failure

Interventions

OTHER: sacubitril/valsartan

Sponsor

Novartis Pharmaceuticals